In This Article:
As the U.S. stock market navigates a mixed landscape, with major indices showing varied movements and recent selloffs impacting investor sentiment, opportunities may arise for those looking to identify stocks that are trading below their estimated value. In such an environment, finding undervalued stocks involves assessing companies with strong fundamentals and potential resilience amid broader market fluctuations.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
Name | Current Price | Fair Value (Est) | Discount (Est) |
German American Bancorp (NasdaqGS:GABC) | $39.82 | $74.94 | 46.9% |
Northwest Bancshares (NasdaqGS:NWBI) | $12.65 | $24.45 | 48.3% |
Old National Bancorp (NasdaqGS:ONB) | $23.97 | $45.88 | 47.8% |
Sandy Spring Bancorp (NasdaqGS:SASR) | $32.99 | $64.53 | 48.9% |
Solaris Energy Infrastructure (NYSE:SEI) | $29.34 | $57.34 | 48.8% |
Incyte (NasdaqGS:INCY) | $71.38 | $135.08 | 47.2% |
Limbach Holdings (NasdaqCM:LMB) | $83.35 | $160.26 | 48% |
Array Technologies (NasdaqGM:ARRY) | $6.90 | $13.50 | 48.9% |
Open Lending (NasdaqGM:LPRO) | $5.44 | $10.49 | 48.2% |
Haemonetics (NYSE:HAE) | $63.45 | $121.99 | 48% |
We'll examine a selection from our screener results.
Bruker
Overview: Bruker Corporation, along with its subsidiaries, is involved in the development, manufacturing, and distribution of scientific instruments and analytical and diagnostic solutions globally, with a market cap of approximately $7.81 billion.
Operations: The company's revenue segments include Bruker Nano at $1.10 billion, Bruker CALID at $1.09 billion, Bruker Biospin at $905.70 million, and Bruker Energy & Supercon Technologies (BEST) at $283 million.
Estimated Discount To Fair Value: 17.3%
Bruker is trading at US$52.92, below its estimated fair value of US$63.96, suggesting it may be undervalued based on cash flows. Despite a decline in profit margins and net income due to large one-off items, earnings are expected to grow significantly over the next three years, outpacing the broader U.S. market. However, Bruker's revenue growth forecast (5.2% annually) lags behind market averages and debt coverage by operating cash flow remains a concern.
-
Our growth report here indicates Bruker may be poised for an improving outlook.
-
Click to explore a detailed breakdown of our findings in Bruker's balance sheet health report.
Fluence Energy
Overview: Fluence Energy, Inc. operates through its subsidiaries to offer energy storage and optimization software for renewable and storage applications across various regions including the Americas, Asia Pacific, Europe, the Middle East, and Africa, with a market cap of approximately $1.34 billion.